Butterfly Network (NYSE:BFLY) FY Conference Transcript

Butterfly Network (NYSE:BFLY) FY Conference Summary Company Overview - Company: Butterfly Network - Industry: Medical Devices, specifically in handheld ultrasound technology Key Points and Arguments Company Progress and Technology - Butterfly Network has evolved from being solely a point-of-care ultrasound company to a broader technology company addressing healthcare challenges [6][10] - The company has made significant advancements in its technology, particularly with the introduction of the Butterfly Embedded initiative and the Octave project [6][7] - The handheld ultrasound market is experiencing growth, with the company emphasizing its unique semiconductor technology that allows for flexibility and programmability [9][11] Partnerships and Collaborations - Butterfly Network has a partnership with Midjourney, which is expected to be a significant revenue stream. Updates on this collaboration are anticipated but are currently limited [7][30] - The company is exploring additional partnerships, with ongoing R&D efforts to integrate its technology with other companies [29][30] - Other notable partnerships include Mendaera, a vascular robotics company, and Sonic Incytes, which focuses on fatty liver technology [29] Market Position and Growth Potential - The company is positioned for sustainable double-digit growth in the handheld point-of-care ultrasound market, with expectations of market inflection in the next 3-5 years [47][51] - Approximately 80% of medical students are being trained on Butterfly technology, indicating a strong foothold in medical education and future market penetration [49] - The company is developing new products, including the iQ Station, which aims to transform the user experience in hospitals by providing personalized, powerful ultrasound devices [53][55] Financial Guidance and Performance - For FY 2026, Butterfly Network projects revenue between $117 million and $121 million, representing a year-over-year increase of 20%-24% [57] - The core business is expected to grow at high single-digit to low double-digit rates, with gross margins projected to exceed 67% [57] - The company is in a strong cash position with over $150 million available, aiming to become cash flow positive by the end of 2027 [58][59] Competitive Landscape - Butterfly Network acknowledges competition from companies like EchoNous and Exo, which utilize different ultrasound technologies. The company respects their potential but believes its technology offers superior performance [41][42] - The company holds 600 patents and has a unique partnership with TSMC, which strengthens its competitive moat in semiconductor manufacturing [35][36] Additional Insights - The integration of AI and sound technology is seen as a transformative opportunity for Butterfly Network, with potential applications in various medical fields [18][21] - The company is focused on addressing the challenges of capturing and reimbursing ultrasound scans, which currently sees a significant percentage of scans going uncaptured [50] Conclusion Butterfly Network is positioned for significant growth in the handheld ultrasound market, driven by innovative technology, strategic partnerships, and a strong focus on education and market awareness. The company is optimistic about its future prospects and is actively working to enhance its product offerings and market presence.